Stacey GandlerBrand Nourishment
Amy GilesIncreasing Engagement
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), ...
Head-to-head phase III study of Alecensa versus crizotinib in Asian patient population showed a ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email